Allergan’s Juvederm Vollure receives FDA approval: 3 key notes

Dublin, Ireland-based Allergan’s Juvederm Vollure received FDA approval.

Advertisement

Here’s what you should know.

1. Juvederm Vollure corrects moderate-to-severe facial wrinkles and folds in adults.

2. Allergan said it’s the first and only FDA-approved dermal filler that lasts up to 18 months.

3. Allergan’s Chief Research and Development Officer David Nicholson, PhD, said the drug demonstrates Allergan’s commitment to developing products that meet people’s needs. In a company press release, Dr. Nicholson said, “This commitment to ongoing scientific research and development is one of the factors that make Juvederm, the number one selling collection of dermal filler products.

More articles on improving health:
8 things to know about patient collections at ASCs
Carl Zeiss Meditec among key vendors in expansive cataract surgery devices market: 5 things to know
6 insights into the cataract surgery market

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.